News

Countries covered by the agreement include Japan, South Korea, China, Taiwan and Singapore and the licensing agreement provides for, among other things, equity payments, milestone payments and double

Samples will be sent from SRL’s territories to Rosetta Genomics’ Philadelphia-based CLIA-certified laboratory for analysis. The terms of the deal were not disclosed. SRL will distribute miRview mets,

Axxima’s assets were transferred to a newly formed holding company in which certain investors injected an additional net E8.7 million in cash. GPC Biotech will purchase the holding

Fortamet (metformin HCl), a treatment for type 2 diabetes, and Atroprev (lovastatin), a cholesterol-managing medicine, are both part of Andrx’ branded products division. First Horizon has agreed to

The basis for the agreed revisions to the prescribing labeling for Crestor, which strengthen points contained in the original labeling, include modifications to dosage instruction; recent clinical trial

Exubera, a dry powder form of insulin that is inhaled into the lungs prior to eating, using a specially designed inhalation device, has been studied in more than

The contracts relate to a series of clinical trials that form part of a global phase II and phase III program investigating the safety and efficacy of an

The patients were treated with an iodine-131 radiolabeled tumor necrosis therapy antibody (131I-TNT). Results showed that approximately 90% of patients treated with 131I-TNT had stable disease or better,

The trial, named NOVA, will evaluate the effects of Biobypass on exercise tolerance, heart function, symptoms and quality of life in approximately 129 patients suffering from moderate to